Resumo
Se ha reportado la meningitis química como una rara reacción adversa secundaria a la administración de un gran número de agentes farmacológicos, con una presentación clínica y unos hallazgos en el líquido cefalorraquídeo (LCR) muy variados que pueden llegar a confundir la etiología del cuadro clínico, donde el diagnóstico está basado en un proceso de exclusión de otras entidades del sistema nervioso central. El artículo presenta el caso de una mujer de 36 años de edad, con antecedente de intervenciones quirúrgicas para la resección de macroadenoma hipofisario, a quien se le quería descartar una fístula del LCR mediante la realización de un cisterno-TAC, con medio de contraste hidrosoluble. Posterior a la realización de este, presentó signos y síntomas sugestivos de meningitis, aun cuando se le descartó meningitis séptica.
Marinac JS. Drug-and chemical-induced aseptic meningitis: a review of the literature. Ann Pharmacother. 1992;26:813-22.
Crook DW, Phuapradit P, Warrell DA. Bacterial meningitis. In: Weatherall DJ, Ledingham JGG, Warrel DA, editors. Oxford textbook of medicine. 3rd ed. Oxford: Oxford Medical Publications; 1996.
Jolles S, Sewell WA, Leighton C. Druginduced aseptic meningitis: diagnosis and management. Drug Saf. 2000;22(3):215-26.
Nakakoshi T, Moriwaka F, Tashiro K, Nakane K, Miyasaka K. Aseptic meningitis complicating iotrolan myelography. AJNR Am J Neuroradiol. 1991;12:173.
Mallat Z, Vassal T, Naouri JF, Prier A, Laredo JD, Offenstadt G. Aseptic meningoencephalitis after iopamidol myelography. Lancet. 1991;338:252.
Zweifler RM, Rothrock JF. Aseptic meningoencephalitis following iohexol myelography. Neuroradiology. 1995;37:148-9.
Viallon A, Zeni F, Lambert C, et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis. 1999;28:1313-6.
Elkin CM, Levan AM, Leeds NE. Tolerance of iohexol, iopamidol, andmetrizamide in lumbar myelography. Surg Neurol. 1986;26:542-6.
Alexiou J, Deloffre D, Vandresse JH, Boucquey JP, Sintzoff S. Postmyelographic meningeal irritation with iohexol. Neuroradiology. 1991;33:85-6.
Berod T, Knebelmann O, Marjou F. Aseptic meningoencephalitis after iopamidol myelography. Ann Pharmacother. 1993;27:1140.
Cissoko H, Lemesle F, Jonville-Bera AP, Autret-Leca E. Aseptic meningitis after iohexol myelography. Ann Pharmacother. 2000;34:812-3.
Mary R, Veinberg F, Couderc R. Acute meningitidis, acute phase proteinsn and procalcitonin. Ann Biol Clin (Paris). 2003;61:127-37.
Lindquist L, Linne T, Hansson LO, Kalin M, Axelsson G. Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis. 1988;7:374-80.
Bender A, Elstner M, Paul R, Straube A. Severe symptomatic aseptic chemical meningitis following myelography: the role procalcitonin. Neurology. 2009;63:1311-3.
Moris G, García-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med. 1999;159:1185-94.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.

